Erythropoiesis-Stimulating Agents for the ManagementOf Anemia of Chronic Kidney Disease: Past Advancements and Current Innovations

Erythropoiesis-Stimulating Agents for the ManagementOf Anemia of Chronic Kidney Disease: Past Advancements and Current Innovations

Identification: nnj_nd12A2
Volume: Vol. 39, No. 6
Issue: November-December 2012

Standard: $30.00

Description

Acknowledgments/Sources of Support/Disclaimers:
Medical writing and editorial assistance provided by Norma Padilla, PhD, and Sophia Shumyatsky, PharmD, of ApotheCom AssociatesSupported by Affymax and Takeda Pharmaceuticals North America, Inc.

Statement of Disclosure:
The author has disclosed that she is a contracted consultant (member and researcher) for Affymax/Takeda Advisory Board. Ms. Dutka has participated in the conduct of numerous clinical trials in the area of anemia management since 1988. The author also wishes to impart that the opinions in this article are her own and are not necessarily those of Winthrop University Hospital, where she is employed.

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.